Navigation Links
Coagulation Self-Testing: Devices, Markets, Players and Prospects
Date:8/1/2011

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Coagulation Self-Testing: Devices, Markets, Players and Prospects

http://www.reportlinker.com/p0581170/Coagulation-Self-Testing-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The ability of patients to self-monitor is deemed to be a critical tool in reducing the pathological effects of difficult-to-control disease factors. For the millions of patients in the US and worldwide prescribed warfarin for oral anticoagulation therapy (OAT), the ability to monitor coagulation rates and adjust drug dosage to optimize therapeutic outcomes is a critical element of patient care. The availability of self-testing monitors provides patients with an opportunity to self-test and avoid frequent caregiver visits. Compared to blood glucose monitoring, OAT self-testing presents a higher level of complexity and risk, placing a premium on patient education. A number of companies are now providing services to patients wishing to self-test, acting as a first-line patient resource and assisting with device selection and patient training. Wirelessly-enabled devices that allow patients to share readings with physicians electronically provide an additional safety and compliance benefit. While still a small percentage of all patients, as demographics and awareness drive increases in the diagnosed incidence of underlying conditions, patient self-testing for OAT will increasingly migrate from caregiver facilities and into homes..

Highlights

• Analyzes marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy

• Evaluates the status and prospects of coagulation self-test devices currently in development

• Assesses the market potential and commercialization risks and opportunities for coagulation self-test devices

• Examines the role and impact of third-party PT/INR self-test services on device demand and patient acceptance

• Provides market data and forecasts to 2015

• Profiles market participants, their technology, product development activity, and business strategies

Executive Summary

Anticoagulation Therapy Market Dynamics

Anticoagulation Economics

Oral Anticoagulation Therapy

Monitoring Prothrombin Time

Competing Anticoagulation Tests

Key Factors in Patient Compliance

Market Drivers

Industry Alignment and Competitive Landscape

Coagulation Self-Testing Device Design Factors

Standardization of PT/INR Testing

Accuracy and Precision

Sampling Method

Endpoint Detection

Patient/User Interface

Connectivity & Data Collection

Commercialization Factors

Managed Care and Reimbursement

Patient Training and Education

Third-Party Self-Testing Services

Market Factors

Regulations and Standards

Patient/Consumer Sentiment

Regional Demand and Demographics

Alliances and Partnerships

Proprietary Technology

Patient Self-Testing Product Assessments

CoaguChek

CoaguSense

InRatio

ProTime

Development-Stage Devices

iLine Microsystems

Microvisk

Universal Biosensors

Zin Technologies

Market Analysis, Data and Forecasts

Indications and Demographics

Therapeutic Market Segments

New Technology & Pipeline Prospects

Geographic Markets

Market Participant Profiles

To order this report:

In Vitro Diagnostic Industry: Coagulation Self-Testing: Devices, Markets, Players and Prospects

In Vitro Diagnostic Business News

More  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
2. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
3. Reportlinker Adds The 2011 US Coagulation Market
4. Roche Introduces CoaguChek Link Web Resource to Streamline Anticoagulation Management for Doctors and Patients
5. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
6. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
7. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
8. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
9. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
10. Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)...  A new study by a pair of Geisinger ... therapy to treat chronic pain is not only ineffective, ... consequences, including death. Palliative care physicians ... , M.D., authored the study which provides a review ... study was published in the December 2016 edition of ...
(Date:12/8/2016)... Information products and services provider Elsevier has launched ... world,s largest abstract and citation database of peer-reviewed literature, providing the ... 5,000 publishers. The new set of metrics will improve decisions on ... adjust a journal,s editorial strategy. ... , CiteScore metrics comprise ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia ... 1, 2017. The name change aligns the entire company with its existing ... care quality. , “We are very proud of the achievements associated with the ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health ... . , Results of the comparative usability study demonstrate that a dictation-based method ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , a ... other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to ... president of sales. , Litsinger joined Mirixa in 2008 after serving as ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
Breaking Medicine News(10 mins):